Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients : incidence and outcome in a French multicenter observational cohort (APICOVID)
© 2024. The Author(s)..
BACKGROUND: Recent studies identified coronavirus disease 2019 (COVID-19) as a risk factor for invasive pulmonary aspergillosis (IPA) but produced conflicting data on IPA incidence and impact on patient outcomes. We aimed to determine the incidence and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA) in mechanically ventilated patients.
METHODS: We performed a multicenter retrospective observational cohort study in consecutive adults admitted to 15 French intensive care units (ICUs) in 2020 for COVID-19 requiring mechanical ventilation. CAPA was diagnosed and graded according to 2020 ECMM/ISHAM consensus criteria. The primary objective was to determine the incidence of proven/probable CAPA, and the secondary objectives were to identify risk factors for proven/probable CAPA and to assess associations between proven/probable CAPA and patient outcomes.
RESULTS: The 708 included patients (522 [73.7%] men) had a mean age of 65.2 ± 10.8 years, a median mechanical ventilation duration of 15.0 [8.0-27.0] days, and a day-90 mortality rate of 28.5%. Underlying immunosuppression was present in 113 (16.0%) patients. Corticosteroids were used in 348 (63.1%) patients. Criteria for probable CAPA were met by 18 (2.5%) patients; no patient had histologically proven CAPA. Older age was the only factor significantly associated with probable CAPA (hazard ratio [HR], 1.04; 95% CI 1.00-1.09; P = 0.04). Probable CAPA was associated with significantly higher day-90 mortality (HR, 2.07; 95% CI 1.32-3.25; P = 0.001) but not with longer mechanical ventilation or ICU length of stay.
CONCLUSION: Probable CAPA is a rare but serious complication of severe COVID-19 requiring mechanical ventilation and is associated with higher day-90 mortality.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Annals of intensive care - 14(2024), 1 vom: 29. Jan., Seite 17 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Desmedt, Luc [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID‑19 |
---|
Anmerkungen: |
Date Revised 01.02.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1186/s13613-023-01229-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36775794X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36775794X | ||
003 | DE-627 | ||
005 | 20240201232224.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240129s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s13613-023-01229-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1277.xml |
035 | |a (DE-627)NLM36775794X | ||
035 | |a (NLM)38285382 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Desmedt, Luc |e verfasserin |4 aut | |
245 | 1 | 0 | |a Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients |b incidence and outcome in a French multicenter observational cohort (APICOVID) |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a BACKGROUND: Recent studies identified coronavirus disease 2019 (COVID-19) as a risk factor for invasive pulmonary aspergillosis (IPA) but produced conflicting data on IPA incidence and impact on patient outcomes. We aimed to determine the incidence and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA) in mechanically ventilated patients | ||
520 | |a METHODS: We performed a multicenter retrospective observational cohort study in consecutive adults admitted to 15 French intensive care units (ICUs) in 2020 for COVID-19 requiring mechanical ventilation. CAPA was diagnosed and graded according to 2020 ECMM/ISHAM consensus criteria. The primary objective was to determine the incidence of proven/probable CAPA, and the secondary objectives were to identify risk factors for proven/probable CAPA and to assess associations between proven/probable CAPA and patient outcomes | ||
520 | |a RESULTS: The 708 included patients (522 [73.7%] men) had a mean age of 65.2 ± 10.8 years, a median mechanical ventilation duration of 15.0 [8.0-27.0] days, and a day-90 mortality rate of 28.5%. Underlying immunosuppression was present in 113 (16.0%) patients. Corticosteroids were used in 348 (63.1%) patients. Criteria for probable CAPA were met by 18 (2.5%) patients; no patient had histologically proven CAPA. Older age was the only factor significantly associated with probable CAPA (hazard ratio [HR], 1.04; 95% CI 1.00-1.09; P = 0.04). Probable CAPA was associated with significantly higher day-90 mortality (HR, 2.07; 95% CI 1.32-3.25; P = 0.001) but not with longer mechanical ventilation or ICU length of stay | ||
520 | |a CONCLUSION: Probable CAPA is a rare but serious complication of severe COVID-19 requiring mechanical ventilation and is associated with higher day-90 mortality | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID‑19 | |
650 | 4 | |a Intensive care unit | |
650 | 4 | |a Invasive pulmonary aspergillosis | |
650 | 4 | |a Mechanical ventilation | |
700 | 1 | |a Raymond, Matthieu |e verfasserin |4 aut | |
700 | 1 | |a Le Thuaut, Aurélie |e verfasserin |4 aut | |
700 | 1 | |a Asfar, Pierre |e verfasserin |4 aut | |
700 | 1 | |a Darreau, Cédric |e verfasserin |4 aut | |
700 | 1 | |a Reizine, Florian |e verfasserin |4 aut | |
700 | 1 | |a Colin, Gwenhaël |e verfasserin |4 aut | |
700 | 1 | |a Auchabie, Johann |e verfasserin |4 aut | |
700 | 1 | |a Lorber, Julien |e verfasserin |4 aut | |
700 | 1 | |a La Combe, Béatrice |e verfasserin |4 aut | |
700 | 1 | |a Kergoat, Pierre |e verfasserin |4 aut | |
700 | 1 | |a Hourmant, Baptiste |e verfasserin |4 aut | |
700 | 1 | |a Delbove, Agathe |e verfasserin |4 aut | |
700 | 1 | |a Frérou, Aurélien |e verfasserin |4 aut | |
700 | 1 | |a Morin, Jean |e verfasserin |4 aut | |
700 | 1 | |a Ergreteau, Pierre Yves |e verfasserin |4 aut | |
700 | 1 | |a Seguin, Philippe |e verfasserin |4 aut | |
700 | 1 | |a Martin, Maëlle |e verfasserin |4 aut | |
700 | 1 | |a Reignier, Jean |e verfasserin |4 aut | |
700 | 1 | |a Lascarrou, Jean-Baptiste |e verfasserin |4 aut | |
700 | 1 | |a Canet, Emmanuel |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of intensive care |d 2012 |g 14(2024), 1 vom: 29. Jan., Seite 17 |w (DE-627)NLM215981812 |x 2110-5820 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2024 |g number:1 |g day:29 |g month:01 |g pages:17 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13613-023-01229-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2024 |e 1 |b 29 |c 01 |h 17 |